# The Safety of Autologous Lyophilized Plasma Versus Fresh Frozen Plasma in Healthy Volunteers

> **NCT00968487** · PHASE1 · COMPLETED · sponsor: **HemCon Medical Technologies, Inc** · enrollment: 16 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** Lyophilized Plasma
- **OTHER:** Fresh Frozen Plasma

## Key facts

- **NCT ID:** NCT00968487
- **Lead sponsor:** HemCon Medical Technologies, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2012-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00968487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00968487, "The Safety of Autologous Lyophilized Plasma Versus Fresh Frozen Plasma in Healthy Volunteers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00968487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*